dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Peñalver, Francisco‐Javier |
dc.contributor.author | Márquez, Jose‐Antonio |
dc.contributor.author | Durán, Soledad |
dc.contributor.author | Giraldo, Pilar |
dc.contributor.author | Martín, Alejandro |
dc.contributor.author | Montalbán, Carlos |
dc.contributor.author | López Hernández, Andrés |
dc.date.accessioned | 2020-07-31T12:38:44Z |
dc.date.available | 2020-07-31T12:38:44Z |
dc.date.issued | 2019-11-01 |
dc.identifier.citation | Peñalver FJ, Márquez JA, Durán S, Giraldo P, Martín A, Montalbán C, et al. Response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first‐line immunochemotherapy: results of the RBMDGELTAMO08 phase II trial. Cancer Med. 2019 Nov 1;8(16):6955–66. |
dc.identifier.issn | 2045-7634 |
dc.identifier.uri | https://hdl.handle.net/11351/5127 |
dc.description | Bendamustina; Limfoma fol·licular; Immunoquimioteràpia |
dc.description.sponsorship | Financial support was provided by Mundipharma Spain and Roche Pharma Spain. |
dc.language.iso | eng |
dc.publisher | Wiley Online Library |
dc.relation.ispartofseries | Cancer Medicine;8(16) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Limfomes |
dc.subject | Medicaments antineoplàstics |
dc.subject | Prognosi |
dc.subject.mesh | Lymphoma, Follicular |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols |
dc.subject.mesh | Prognosis |
dc.title | Response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first‐line immunochemotherapy: results of the RBMDGELTAMO08 phase II trial |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1002/cam4.2555 |
dc.subject.decs | linfoma folicular |
dc.subject.decs | protocolos de quimioterapia antineoplásica combinada |
dc.subject.decs | Pronóstico |
dc.relation.publishversion | https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.2555 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Peñalver FJ] Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain. [Márquez JA] Hospital de Basurto, Vizcaya, Spain. [Durán S] Complejo Hospitalario de Jaén, Jaén, Spain. [Giraldo P] Hospital Universitario Miguel Servet, Zaragoza, Spain. [Martín A] Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain. [Montalbán C] Hospital Universitario Ramón y Cajal, Madrid, Spain. [López A] Vall d'Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 31573746 |
dc.identifier.wos | 000488578100001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |